Immune System Diseases

The ALL-MED Specialistyczna Opieka Medyczna. Medyczny Instytut Badawczy is conducting studies that target disorders of the immune system, focusing on severe asthma phenotypes and chronic urticaria.

  • Chronic Spontaneous Urticaria
  • Severe Asthma
  • Severe asthma with an eosinophilic phenotype

Trials aim to evaluate the safety and efficacy of emerging biologic therapies, offering potential new treatment options for patients whose conditions are difficult to control with standard care.

Otorhinolaryngologic Diseases

Research at the site emphasizes allergic diseases of the nose and eyes, investigating innovative approaches to reduce symptoms caused by seasonal and perennial allergens.

  • Birch Pollen-induced Allergic Rhinoconjunctivitis
  • Birch pollen induced allergic rhinitis or rhinoconjunctivitis
  • Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma induced by House Dust Mite (HDM) Allergy
  • Perennial Allergic Rhinitis (PAR)
  • Seasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposure
  • Seasonal allergic rhinitis and/or rhinoconjunctivitis

The goal is to assess the clinical benefit of subcutaneous allergen immunotherapy and related treatments, improving quality of life for individuals suffering from chronic nasal and ocular allergy.

Respiratory Tract Diseases

The institute’s respiratory program concentrates on severe asthma, especially forms linked to eosinophilic inflammation, seeking to broaden therapeutic options.

  • Severe Asthma
  • Severe asthma with an eosinophilic phenotype

Ongoing studies evaluate novel anti‑IL-5 and anti‑IL-4 agents for their ability to reduce exacerbations and improve lung function in patients with uncontrolled disease.

Skin and Connective Tissue Diseases

Investigations into dermatologic immune conditions focus on chronic urticaria, a condition marked by recurrent hives and itching.

  • Chronic Spontaneous Urticaria

The research assesses the effectiveness of new monoclonal antibody treatments compared with placebo, targeting symptom relief and disease control.